Abstract
Paediatric Hodgkin disease presents some particularities when compared to Hodgkin in adults. In this article, we focus on the paediatric particularities, especially in term of current treatment strategy. The aim is to decrease the important rate of late effects while keeping the excellent survival.
MeSH terms
-
Adolescent
-
Adult
-
Aging / physiology
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use
-
Child
-
France / epidemiology
-
Hodgkin Disease / drug therapy
-
Hodgkin Disease / epidemiology
-
Hodgkin Disease / radiotherapy*
-
Humans
-
Incidence
-
Radiotherapy Dosage
-
Young Adult